(SeeNews) - May 30, 2012 - Chinese firm Guangxi Beisheng Pharmaceutical (SHA:600556) will acquire mono- and polycrystalline ingot maker Zhejiang Topoint Photovoltaic in an asset restructuring plan, Securities Times said, quoting a company filing on Tuesday.